Associations of leisure-time physical activity and television viewing with life expectancy cancer-free at age 50: The ARIC study by Cuthbertson, C.C. et al.
Associations of Leisure-Time Physical Activity and
Television Viewing with Life Expectancy Cancer-Free at
Age 50: The ARIC Study
Carmen C. Cuthbertson1, Hazel B. Nichols1, Xianming Tan2, Anna Kucharska-Newton1, Gerardo Heiss1,
Corinne E. Joshu3, Elizabeth A. Platz3, and Kelly R. Evenson1
ABSTRACT
◥
Background: Physical activity has been associated with longer
chronic disease–free life expectancy, but specific cancer types have
not been investigated. We examined whether leisure-time moder-
ate-to-vigorous physical activity (LTPA) and television (TV) view-
ing were associated with life expectancy cancer-free.
Methods: We included 14,508 participants without a cancer
history from the Atherosclerosis Risk in Communities (ARIC)
study. We used multistate survival models to separately examine
associations of LTPA (no LTPA, <median, ≥median) and TV
viewing (seldom/never, sometimes, often/very often)with life expec-
tancy cancer-free at age 50 from invasive colorectal, lung, prostate,
and postmenopausal breast cancer. Models were adjusted for age,
gender, race, ARIC center, education, smoking, and alcohol intake.
Results: Compared with no LTPA, participants who engaged in
LTPA ≥median had a greater life expectancy cancer-free from
colorectal [men-2.2 years (95% confidence interval (CI), 1.7–2.7),
women-2.3 years (95% CI, 1.7–2.8)], lung [men-2.1 years (95% CI,
1.5–2.6), women-2.1 years (95% CI, 1.6–2.7)], prostate [1.5 years
(95% CI, 0.8–2.2)], and postmenopausal breast cancer [2.4 years
(95% CI, 1.4–3.3)]. Compared with watching TV often/very
often, participants who seldom/never watched TV had a greater
colorectal, lung, and postmenopausal breast cancer-free life expec-
tancy of 1 year.
Conclusions: Participating in LTPA was associated with longer
life expectancy cancer-free from colorectal, lung, prostate, and
postmenopausal breast cancer. Viewing less TV was associated
with more years lived cancer-free from colorectal, lung, and post-
menopausal breast cancer.
Impact: Increasing physical activity and reducing TV viewing
may extend the number of years lived cancer-free.
Introduction
Cancer contributes significantly to years lived with disability and to
the risk of mortality (1). In the United States, 16.9 million men and
women have a cancer history and an estimated 1.8 million cases are
projected to occur in 2020 (2). Prostate, breast (pre- and postmeno-
pausal), lung and bronchus, and colorectal cancer are the most
frequently diagnosed cancers in the United States (2). The number
of years lived without cancer can be estimated with health expectancy
outcomes, a measure that combines incidence and mortality to
estimate life expectancy lived with and without disease (3). Health
expectancy outcomes can complement population-based measures,
such as life expectancy, by estimating years of life lived in good health
and lost to poor health (3).
Physical activity has been associated with a lower risk of many types
of cancer (4–6), longer survival after cancer diagnosis (6–8), and longer
life expectancy (9). Recent studies on physical activity and health
expectancy outcomes have observed that greater amounts of physical
activity were associated with longer life expectancy disease-free from
cardiovascular disease (CVD; refs. 10–14), diabetes (15), and chronic
disease (definitions varied by study but have included composite
measures of coronary heart disease, stroke, diabetes, lung disease,
cancer, asthma, and arthritis; refs. 16–20) but no studies have sepa-
rately examined specific cancer types. Sedentary behavior, conversely,
has been associated with an increased risk of incident cancer (21) and
all-cause mortality (22). To date, sedentary behavior has not been
examined in relation to cancer health expectancy outcomes.
Given the large population burden of cancer, we sought to under-
stand how two health behaviors, physical activity and less sedentary
behavior, could extend the years lived cancer-free. Therefore, we
examined how physical activity and television (TV) viewing, a com-
mon type of sedentary behavior, were associated with life expectancy
cancer-free at age 50 from four leading types of cancer—colorectal,
lung, prostate, and postmenopausal breast cancer, in a population-




We used data from the ARIC study, a prospective cohort of 15,792
mostly White and African-American adults. Participants, ages 44 to
66 years at visit 1, were enrolled from four geographic areas in the
United States (Forsyth County, North Carolina; Jackson, Mississippi;
Washington County, Maryland; and Minneapolis, Minnesota). ARIC
study cohort members have participated in interviews, clinical exam-
inations, and annual (semi-annual from 2012) telephone follow-up
interviews over seven examination visits (visit 1 1987–1989, visit 2
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state cancer registries were not complete or established at the start of
the ARIC study, and for this time period, cancer cases were identified
by surveillance of hospital discharge summaries in the ARIC study
regions supplemented withmedical record abstraction (29). The ARIC
Cancer Coordinating Center adjudicated all potential cases of colo-
rectal, lung, prostate, and postmenopausal breast cancers (29). For the
purpose of exclusions, participants were considered to have prevalent
cancer at visit 1 if they said a doctor told them that they had cancer of
any type.
Deaths were ascertained from visit 1 until December 31, 2012,
through active surveillance of vital status and by linkage with the
National Death Index (23, 30).
Covariate assessment
Confounders were selected on the basis of a priori knowledge of the
relationship of physical activity and sedentary behavior with cancer
incidence and all-cause mortality (5, 21, 31–35). Covariates measured
at visit 1 included age (continuous), gender (male, female), race by
ARIC center (African-American Forsyth county, White Forsyth
County, African-American Jackson, White Minneapolis, White
Washington County), education (≤high school, vocational school,
some college/college degree, graduate/professional), daily servings of
red meat intake (continuous), and smoking pack-years (continuous;
Supplementary Materials and Methods). Time-varying covariates
that were assessed at visits 1 to 4 included: smoking status (current
smoker, past smoker, never smoker), alcohol intake (not current
drinker, ≤100 g, >100 g), body mass index (BMI; underweight/normal
<25.0 kg/m2, overweight 25.0–<30 kg/m2, obese ≥30.0 kg/m2),
diabetes (yes, no), and in women, use of menopausal hormone therapy
(MHT; never users, former users of any MHT type, current users
of unopposed estrogen, current users of estrogen plus progestin)
and postmenopausal status (premenopausal, postmenopausal)
(Supplementary Materials and Methods).
For the analysis on postmenopausal breast cancer, we included
only postmenopausal women. Women were considered postmen-
opausal at the ARIC visit in which they reported the following: (i)
having both ovaries removed; (ii) if both ovaries had not been
removed, they were not taking hormones, and had not had a
hysterectomy, then they were considered menopausal when they
reported reaching menopause or having no periods in the past two
years; or (iii) if both ovaries had not been removed but women
reported taking hormones, had a hysterectomy, or did not know
their menopause status, then they were considered menopausal
when they reached the average cohort race- and smoking status–
specific age when menopause was reached (White: never 48.3,
former 47.3, current 46.6; African American: never 47.8, former
47.0, current 45.6 years).
Statistical analysis
We used multistate Markov survival models to estimate how
participants moved between health (state 1), disease (state 2), and
all-cause mortality (state 3) states (Fig. 1; Supplementary Materials
and Methods and Supplementary Table S1). This model had three
possible transitions—health to disease (T1), health to all-cause mor-
tality (T2), and disease to all-cause mortality (T3). All participants
started in the health state, free of cancer, and could move to the disease
state (T1) or to death from any cause (T2). Participants who developed
cancer could move from the disease state to the death state (T3).
Separate models were specified with different disease states: colorectal,
lung, prostate, and postmenopausal breast cancer. Transition-specific
(T1, T2, T3) hazard ratios (HR) and 95% confidence intervals (CI)
1990–1992, visit 3 1993–1995, visit 4 1996–1998, visit 5 2011–2013, 
visit 6 2016–2017, and visit 7 2018–2019; ref. 23). All participants 
provided informed written consent at each study visit. The ARIC study 
was approved by the Institutional Review Boards at all participating 
institutions.
For this analysis, we excluded participants who did not consent to 
non-CVD research (n ¼ 149), those with a history of any type of 
cancer at baseline (n ¼ 902), and those who experienced cancer 
(colorectal, lung, prostate, or breast) or death within the first year of 
follow-up to reduce the likelihood of reverse causation (n ¼ 130). 
Due to small numbers of race/ethnic groups at ARIC sites, we also 
excluded Asian and American Indian/Alaskan Indian participants 
(Forsyth County n ¼ 21, Minnesota n ¼ 15, Washington County n 
¼ 12) and African-American participants in Minnesota (n ¼ 22) 
and Washington County (n ¼ 33). After exclusions, 14,508 (92%) 
participants were included in analysis for colorectal and lung 
models, 6,582 men for prostate models, and 7,849 postmenopausal 
women for postmenopausal breast models (77 women were not 
included in breast cancer models because they died or developed 
breast cancer before reaching menopause).
Physical activity and sedentary behavior
Participants reported engaging in sport or exercise activities 
in the past year with the Baecke questionnaire at visits 1 and 
3 (24, 25). Participants could report up to four leisure-time physical 
activities (LTPA). For each activity, participants were asked to 
report the number of hours/week and months/year they engaged 
in the activity. A metabolic equivalent of task (MET) value was 
assigned to each activity based on the compendium of physical 
activities (26). Activities with a MET ≥3 were classified as moderate-
to-vigorous intensity (27). MET hours per week (MET-h/week) 
spent in moderate-to-vigorous LTPA at visits 1 and 3 was catego-
rized as none, <median (0.1–<13.2 MET-h/week), and ≥median 
(13.2þ MET-h/week). The cut point was based on the visit 1 median 
value of MET-h/week among those reporting any LTPA. In a 
supplemental analysis, to further enhance the translation of our 
results, we classified participants as meeting the 2018 U.S. physical 
activity guidelines of participating in at least 150 minutes/week of 
moderate intensity activity, or 75 minutes/week of vigorous inten-
sity activity, or an equivalent combination (27). We classified 
participants as no LTPA participation, LTPA less than guidelines 
(0.1<7.5 MET-h/week), met guidelines (7.5–<15.0 MET-h/week), 
and doubled guidelines (15.0þ MET-h/week).
Sedentary behavior, any waking behavior that expends little energy 
expenditure (≤1.5 MET) while in a sitting or reclining posture (28), 
was estimated with a question on TV viewing. Participants reported at 
visit 1 how often they viewed TV and were classified as never/seldom, 
sometimes, and often/very often, due to small numbers in some 
categories.
Cancer and all-cause mortality outcomes
We focused on four leading types of cancer—colorectal, lung, 
prostate, and postmenopausal breast—which accounted for 59% of 
cancer diagnoses in ARIC. First primary invasive cancer diagnoses 
were ascertained by linkage with statewide cancer registries from 1987 
to December 31, 2012, and supplemented by abstraction of medical 
records and hospital discharge codes. In addition to the cancer registry 
linkage, participants who self-reported a cancer diagnosis at an annual/
semi-annual interview or at an ARIC study visit were contacted for 
further information and their medical records were abstracted to 
confirm a cancer diagnosis and tumor characteristics. Some of the
ther adjustment for BMI (all models), MHT (breast cancer LTPA
model), red meat intake (colorectal LTPAmodel), diabetes (colorectal
LTPA model), smoking pack-years (lung LTPA model), restriction to
never smokers [colorectal, prostate, and breast cancer LTPA models,
lung cancer models would not converge possibly due to the small
number of lung cancer cases among never smokers (n ¼ 10)],
and exclusion of cases that occurred within 5 years of baseline (lung
LTPA model).
Missing exposure and covariate data that occurred at each visit were
imputed with multiple imputation by chained equations (Supplemen-
tary Materials andMethods; refs. 39, 40). All analyses were carried out
with SAS Version 9.4 and R Version 3.3.2. Analyses were approved by
the Institutional Review Board at the University of North Carolina at
Chapel Hill.
Results
At baseline, the average age of the 14,508 participants was
54 years (SD 5.7), 55% were female, 28% were African American,
56% had a high school education or less, most participants were not
current smokers or current drinkers, and 89% of women were
postmenopausal (Table 1). Over 60% of participants reported
any LTPA and the median amount of LTPA at baseline was 13.2
MET-h/week. Close to half of participants reported watching TV
sometimes.
Over a median 23.6 years of follow-up, 2,360 (16.3%) participants
had a diagnosis of incident invasive first primary colorectal, lung,
prostate, or postmenopausal breast cancer and 5,054 (34.8%) deaths
from all causes occurred in the full analytic cohort. The mean age at
cancer diagnosis was 68.8 years (SD 7.5) for colorectal, 69.7 years
(SD 7.3) for lung, 68.6 years (SD 6.3) for prostate, and 66.7 years
(SD 7.3) for postmenopausal breast cancer. HRs for LTPA and TV
viewing with each transition (T1, T2, T3) are in Supplementary
Tables S2 and S3.
Figure 1.
Three-state multistate models used for analysis. Four sets of models were estimated separately for each cancer site: colorectal (A), lung (B), prostate (C), and
postmenopausal breast (D) cancer. In each type of model all participants started in the health state (free of cancer) and could move to state 2 if they developed the
cancer under analysis or could move to state 3, death from any cause. Those who developed cancer couldmove from the cancer state to all-causemortality from the
cancer state. The arrows indicate transitions between each state and are labeled T1 (transition from state 1 to state 2), T2 (transition from state 1 to state 3), and T3
(transition from state 2 to state 3). Once a participant entered a state they remained in that state until they experienced a transition or were censored at the end of
study follow-up. The number of participants who experienced each type of transition for each of the four models is in parentheses. T, transition.
were estimated with the msm R package (36, 37). The time scale for all 
models was age; participants started contributing time to the study at 
the age they entered at visit 1. For breast cancer analyses, women 
started contributing time at the age of their first visit in which they 
were considered postmenopausal. Follow-up continued until death 
or end of study (December 31, 2012). For time-varying covariates, 
information from the visit closest in time preceding each type of 
transition was used for the specific transition. Exposures and 
covariates were used on all transitions (T1, T2, T3) and did not 
vary by type of transition.
Life expectancy, the expected average number of remaining years 
of life in health and disease states conditional on reaching age 50 
and regardless of health status at age 50, was estimated with the R 
package Estimating Life Expectancies in Continuous Time (ELECT; 
ref. 38). The ELECT package uses model parameters estimated from 
the multistate models. Total life expectancy was divided into life 
expectancy with and without disease. CIs were estimated using 
1,000 bootstrap samples. We focused on life expectancy cancer-free, 
which was derived from the T1 and T2 transitions from the 
multistate models and accounted for time from age 50 until incident 
cancer diagnosis, death, or end of study, whichever occurred first. 
We estimated life expectancy at age 50 to compare with studies on 
physical activity and life expectancy disease-free that all estimated 
life expectancy at age 50 (10–13, 15–18, 20). Across models, life 
expectancies were estimated at each level of LTPA (no LTPA, LTPA 
<median, and LTPA ≥median) and TV viewing (often/very often, 
sometimes, seldom/never) while specifying other covariates used in 
analytic models to the baseline covariate distribution levels of the 
analytic cohort.
First, we specified models that separately examined LTPA and TV, 
and then specified models that included both LTPA and TV. 
For all models, we adjusted for age, gender, race by ARIC center, 
education, smoking, and alcohol intake. We conducted sensitivity 
analyses (Supplementary Materials and Methods) that included fur-
LTPA and life expectancy cancer-free
On average, participants could expect to live more than 20 years
cancer-free given they were alive at age 50; for each cancer type, life
expectancy cancer-free was greater for women than men at each
level of LTPA. Participation in LTPA showed a positive dose–
response relationship with greater life expectancy cancer-free
(Fig. 2). Participants who engaged in LTPA <median had 1 year
greater life expectancy cancer-free from colorectal, lung, and breast
cancer compared with participants who reported no LTPA.
At LTPA ≥median compared with none, participants had a
greater life expectancy cancer-free of over 2 years from colorectal
[men-2.2 years (95% CI, 1.7–2.7), women-2.3 years (95% CI, 1.7–
2.8)], lung [men-2.1 years (95% CI, 1.5–2.6), women-2.1 years (95%
CI, 1.6–2.7)], and breast cancer [2.4 years (95% CI, 1.4–3.3)], and
over 1 year for prostate cancer [1.5 years (95% CI, 0.8–2.2)].
Compared with no LTPA, life expectancy cancer-free was greater
Table 1. Baseline characteristics of ARIC study participants, n ¼ 14,508.
Leisure-time physical activity TV viewing
None <Median ≥Median Seldom/never Sometimes Often/very often Overall
N ¼ 5,615 N ¼ 4,424 N ¼ 4,446 N ¼ 2,670 N ¼ 6,779 N ¼ 5,030 N ¼ 14,508
Age at visit 1, mean (SD) 54.4 (5.7) 54.4 (5.8) 54.7 (5.8) 54.0 (5.7) 54.4 (5.7) 54.9 (5.8) 54.3 (5.7)
Male, n (%) 2,312 (41) 1,801 (41) 2,454 (55) 1,098 (41) 2,905 (43) 2,562 (51) 6,582 (45)
ARIC center, n (%)
Forsyth County, NC 1,175 (21) 1,207 (27) 1,297 (29) 705 (26) 1,759 (26) 1,213 (24) 3,682 (25)
Jackson, MS 2,119 (38) 784 (18) 616 (14) 400 (15) 1,634 (24) 1,485 (30) 3,536 (24)
Minneapolis, MN 953 (17) 1,269 (29) 1,417 (32) 845 (32) 1,644 (24) 1,150 (23) 3,640 (25)
Washington County, MD 1,368 (24) 1,164 (26) 1,116 (25) 720 (27) 1,742 (26) 1,182 (24) 3,650 (25)
Race, n (%)
White 3,313 (59) 3,465 (78) 3,730 (84) 2,224 (83) 4,982 (74) 3,296 (66) 10,514 (73)
African American 2,302 (41) 959 (22) 716 (16) 446 (17) 1,797 (27) 1,734 (35) 3,994 (28)
Education, n (%)
High school or less 3,771 (67) 2,383 (54) 1,984 (45) 1,292 (49) 3,747 (55) 3,094 (62) 8,155 (56)
Vocational 414 (7) 405 (9) 385 (9) 215 (8) 566 (8) 422 (8) 1,205 (8)
College 1,019 (18) 1,214 (28) 1,443 (33) 818 (31) 1,752 (26) 1,106 (22) 3,679 (25)
graduate/professional 399 (7) 418 (10) 627 (14) 341 (13) 705 (10) 398 (8) 1,445 (10)
Missing 12 4 7 4 9 10 24
LTPAa, n (%)
No LTPA 849 (32) 2,603 (38) 2,161 (43) 5,615 (39)
<Median 805 (30) 2,042 (30) 1,575 (31) 4,424 (31)
≥Median 1,016 (38) 2,134 (32) 1,294 (26) 4,446 (31)
Missing 0 0 0 23
TV viewing, n (%)
Seldom/never 849 (15) 805 (18) 1,016 (23) 2,670 (18)
Sometimes 2,603 (46) 2,042 (46) 2,134 (48) 6,779 (47)
Often/very often 2,161 (39) 1,575 (36) 1,294 (29) 5,030 (35)
Missing 2 2 2 29
Smoking, n (%)
Current smoker 1,803 (32) 1,058 (24) 890 (20) 543 (20) 1,650 (24) 1,557 (31) 3,760 (26)
Past smoker 1,510 (27) 1,409 (32) 1,739 (39) 867 (33) 2,153 (32) 1,638 (33) 4,665 (32)
Never smoker 2,298 (41) 1,955 (44) 1,812 (41) 1,257 (47) 2,974 (44) 1,829 (36) 6,071 (42)
Missing 4 2 5 3 2 6 12
Alcohol intake, n (%)
Not current drinker 3,774 (68) 2,707 (62) 2,348 (53) 1,621 (61) 4,182 (62) 3,020 (61) 8,835 (61)
≤100 g 1,100 (20) 1,124 (26) 1,342 (30) 694 (26) 1,672 (25) 1,200 (24) 3,566 (25)
>100 g 700 (13) 574 (13) 731 (17) 344 (13) 887 (13) 774 (16) 2,007 (14)
Missing 41 19 25 11 38 36 100
BMI, mean (SD) 28.7 (6.0) 27.4 (5.2) 26.9 (4.6) 26.9 (5.0) 27.7 (5.4) 28.3 (5.6) 27.8 (5.4)
Missing 6 3 2 2 2 7 23
MHT, n (%)
Current user of unopposed estrogen 409 (13) 335 (13) 276 (14) 194 (13) 512 (14) 314 (13) 1,020 (14)
Current user of estrogen þ progestin 103 (3) 154 (6) 165 (9) 114 (8) 220 (6) 88 (4) 422 (6)
Never used 2,194 (70) 1,650 (66) 1,175 (62) 983 (65) 2,440 (66) 1,592 (68) 5,019 (66)
Former user of any type 421 (14) 380 (15) 296 (16) 222 (15) 511 (14) 364 (15) 1,097 (15)
Missing 147 80 56 42 158 83 291
Postmenopausal, n (%) 2,948 (90) 2,303 (89) 1,730 (88) 1,322 (85) 3,427 (89) 2,228 (91) 6,988 (89)
Missing 0 0 0 0 0 0 0
Daily servings of red meat intake, mean (SD) 1.2 (1.0) 1.1 (0.8) 1.0 (0.8) 1.0 (0.8) 1.1 (0.8) 1.2 (1.0) 1.1 (0.9)
Missing 12 4 11 1 16 10 42
aLTPA categories: <median (0.1<13.2 MET-h/week), ≥median (13.2þ MET-h/week).
Sensitivity analyses
Life expectancy cancer-free was similar or modestly lower when
further adjusting for BMI (all models), red meat or diabetes status
(colorectal LTPAmodel),MHT (breast cancer LTPAmodel), smoking
pack-years (lung cancer LTPA model), restricting to never smokers
(colorectal, prostate, breast cancer LTPA models), or when excluding
cases diagnosed within 5 years of baseline (lung cancer LTPA model;
Supplementary Tables S5–S8).
Discussion
In this population-based cohort of White and African-American
adults, participation in any LTPA and viewing less TV were
associated with extended life expectancy cancer-free from major
common cancers. Participation in LTPA showed a positive dose–
response relationship with life expectancy cancer-free, such that at
each level of LTPA participation life expectancy cancer-free was
greater by approximately 1 year. Compared with no LTPA partic-
ipation, at LTPA <median and ≥median life expectancy cancer-free
was approximately 1 and 2 years greater, respectively. Viewing TV
sometimes or seldom/never compared with often/very often was
associated with a longer life expectancy cancer-free, but the mag-
nitude of associations was more modest than those observed for
LTPA. Life expectancy cancer-free findings were similar in mag-
nitude for colorectal, lung, and breast cancer but the years lived
disease-free were lower for prostate cancer compared with the other
cancers.
Our findings are consistent with those of other studies on physical
activity and chronic disease–free life expectancy. Higher levels of
physical activity compared with lower levels or none have been
associated with a greater life expectancy disease-free of 2 to 3 years
for CVD (10–12), 4 years for diabetes (15), and 1 to 6 years for chronic
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Figure 2.
Life expectancy (years, 95% CI) cancer-free from four cancer types and life expectancy differences at age 50 by LTPA among ARIC participants (1987–2012). LTPA
categories included none, <median (0.1<13.2MET-h/week), and≥median (13.2þMET-h/week). Modelswere specified separately for each type of cancer (colorectal
cancer and lung cancer modelsN¼ 14,508, prostate cancer modelsN¼ 6582, and postmenopausal breast cancer modelsN¼ 7,849). Models were adjusted for age,
gender, race by ARIC center, education, smoking status, and alcohol intake. Prostate and breast models did not include gender. CRC, colorectal cancer; LE, life
expectancy.
by 1 year for LTPA less than the guidelines, 1.4 years for 
meeting physical activity guidelines, and by 2.4 years for doubling 
the guidelines for most cancers (Supplementary Table S4).
TV viewing and life expectancy cancer-free
Life expectancy cancer-free was longer for viewing TV sometimes 
and seldom/never compared with often/very often for colorectal, 
lung, and breast cancer and was greater for women than men for 
each cancer type (Fig. 3). Compared with often/very often viewing 
TV, viewing TV seldom/never was associated with a greater life 
expectancy cancer-free of 1 year from colorectal [men-1.2 years 
(95% CI, 0.5–1.9), women-1.2 years (95% CI, 0.6–1.9)], lung [men-
1.4 years (95% CI, 0.7–2.0), women-1.4 years (95% CI, 0.7–2.1)], 
and breast cancer [women-1.4 years (95% CI, 0.4–2.4)]. However, 
for prostate cancer, seldom/never watching TV compared with 
often/very often was not associated with longer life expectancy 
cancer-free [0.5 years (95% CI, 0.4 to 1.3)].
Combined LTPA and TV viewing with life expectancy 
cancer-free
For all types of cancer, participating in more LTPA and viewing less 
TV were associated in a dose–response fashion with life expectancy 
cancer-free (Fig. 4). For colorectal, lung, and breast cancer, life 
expectancy cancer-free was greater by 3 years for engaging in LTPA 
≥ median and seldom/never viewing TV compared with the referent 
group of no LTPA and often/very often viewing TV [colorectal: men-
3.2 years (95% CI, 2.4–4.0), women-3.3 years (95% CI, 2.4–4.1); lung: 
men-3.3 years (95% CI, 2.5–4.1), women-3.4 years (95% CI, 2.5–4.2); 
breast: 3.5 years (95% CI, 2.2–4.8)]. For prostate cancer, the life 
expectancy cancer-free was 2 years longer for LTPA ≥median and 
seldom/never viewing TV [1.9 years (95% CI, 0.9–3.0)] compared with 
the referent group of no LTPA and often/very often viewing TV.
disease (16–18, 20). Similar to other reports (10, 11, 13–16, 18, 20), life
expectancy disease-free by level of physical activity was higher for
women than men. Our work complements these studies by exam-
ining four leading cancer types. For colorectal, lung, and breast
cancer, at LTPA <median, life expectancy cancer-free was approx-
imately 1 year greater, compared with no LTPA participation.
Also, for the same cancers, at LTPA ≥median, the life expectancy
estimates were 2 years greater compared with no LTPA. Physical
activity is hypothesized to lower cancer risk by reducing adiposity,
enhancing immune function, lowering levels of sex hormones,
improving insulin sensitivity, and for colorectal cancer, by reducing
bowel transit time (41, 42).
We specified LTPA as MET-h/week to enhance the translation of
our findings. One can reach 13.2 MET-h/week (the median level of
LTPA in our sample) by taking a brisk walk (at 3.3 METs) for 48
minutes/day for 5 days of the week. In addition, life expectancy
cancer-free was greater by 1.4 years for meeting the 2018 U.S.
physical activity guidelines and by 2.4 years for doubling the
guidelines for most cancers compared with no LTPA. One can reach
the guidelines (7.5 MET-h/week) by taking a brisk walk for 28
minutes/day for 5 days of the week. Even at activity levels less than
the guidelines, we observed greater life expectancy cancer-free of1
year, suggesting that physical activity levels lower than the recom-
mendations were associated with more years lived cancer-free.
According to a recent analysis with 2003 to 2006 NHANES data,
the average MET-h/week of self-reported LTPA was 14.2 MET-h/
week, but only 64% of adults age 40 and older reported participating
in any LTPA (43). Similar to the NHANES prevalence of engaging
in any LTPA, 61% of our analytic sample reported participating in
any LTPA. On the basis of our observational findings, it is likely that
if population levels of physical activity increased, that more years of
life would be spent in health rather than managing the morbidity
related to certain cancer diagnoses.
For colorectal, lung, and postmenopausal breast cancer, viewing TV
sometimes or seldom/never was associated with 1 year gain in life
expectancy cancer-free compared with often/very often watching TV.
To our knowledge, no other studies on life expectancy disease-free
have examined sedentary behavior, but the direction of our associa-
tions of TV viewing with cancer incidence and all-cause mortality are
consistent with existing findings (21, 44–50). In addition, we found
that life expectancy cancer-free was increased by 3.5 years for
seldom/never viewing TV and engaging in LTPA greater than or at
the median compared with those who did no LTPA and often/very
often viewed TV for most cancers. This finding suggests that engage-
ment in multiple health promoting behaviors can further extend the
years lived cancer-free.
Our study has a number of strengths. Most importantly, we used
health expectancy metrics to examine how health behaviors influ-
enced years lived cancer-free (3). Presenting the number of years
one is expected to live healthy, free of cancer, is likely to be of
interest to many people and may be an effective motivational tool
for behavior change. To estimate health expectancies, we used
multistate survival models, which allow participants to move
between multiple health states and handle the competing risk of
disease events and death. In addition, we observed the results from
multiple sensitivity analyses to be robust to adjustment for many
factors. We used time-varying exposures and covariates to update
behaviors as they changed throughout follow-up and addressed
missing exposure and covariate data with multiple imputation
techniques. Although we used a time-varying measure of physical
activity and a baseline measure of TV viewing, it is possible these
behaviors changed after the last measurement of each.
Despite the strengths of our study, limitations should be considered.
We did not account for physical activity from travel, occupation, and
housework and it is possible that the strength of observed associations
would be greater if activity from multiple domains were included. In
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Figure 3.
Life expectancy (years, 95% CI) cancer-free from four cancer types and life expectancy differences at age 50 by TV viewing among ARIC participants (1987–2012).
Models were specified separately for each type of cancer (colorectal cancer and lung cancer models N ¼ 14,508, prostate cancer models N ¼ 6,582, and
postmenopausal breast cancer models N ¼ 7,849). Models were adjusted for age, gender, race by ARIC center, education, smoking status, and alcohol intake.
Prostate and breast models did not include gender. CRC, colorectal cancer; LE, life expectancy.
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Figure 4.
Life expectancy (years, 95% CI) cancer-free from (A) colorectal cancer, (B) lung cancer, (C) prostate cancer, and (D) postmenopausal breast cancer and
life expectancy differences at age 50 by LTPA and TV viewing among ARIC participants (1987–2012). LTPA categories included none, <median (0.1< 13.2
MET-h/week), and ≥median (13.2þ MET-h/week). TV categories included high TV (viewing often/very often), some TV (sometimes viewing), and low TV
(seldom/never viewing). Models were specified separately for each type of cancer (colorectal cancer and lung cancer models N ¼ 14,508, prostate cancer
models N ¼ 6,582, and postmenopausal breast cancer models N ¼ 7,849). Models were adjusted for age, gender, race by ARIC center, education, smoking
status, and alcohol intake. Prostate and breast models did not include gender. CRC, colorectal cancer; LE, life expectancy.
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